319 related articles for article (PubMed ID: 28624170)
1. Predictors of visit-to-visit blood pressure variability in patients with hypertension: an analysis of trials with an amlodipine treatment arm.
Wang JG; Zhou D; Jeffers BW
J Am Soc Hypertens; 2017 Jul; 11(7):402-411. PubMed ID: 28624170
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Visit-to-Visit Blood Pressure Variability (BPV) and Kidney Function in Patients with Hypertension.
Jeffers BW; Zhou D
Kidney Blood Press Res; 2017; 42(4):697-707. PubMed ID: 29045941
[TBL] [Abstract][Full Text] [Related]
3. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Wang JG; Yan P; Jeffers BW
J Am Soc Hypertens; 2014 May; 8(5):340-9. PubMed ID: 24685006
[TBL] [Abstract][Full Text] [Related]
4. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study.
Zhang Y; Agnoletti D; Safar ME; Blacher J
Hypertension; 2011 Aug; 58(2):155-60. PubMed ID: 21747047
[TBL] [Abstract][Full Text] [Related]
5. Effect of visit-to-visit blood pressure variability on cardiovascular events in patients with coronary artery disease and well-controlled blood pressure.
Park S; Yan P; Cerezo C; Jeffers BW
J Am Soc Hypertens; 2016 Oct; 10(10):799-810. PubMed ID: 27720066
[TBL] [Abstract][Full Text] [Related]
6. Relationship of Inter-Individual Blood Pressure Variability and the Risk for Recurrent Stroke.
Kim BJ; Kwon SU; Wajsbrot D; Koo J; Park JM; Jeffers BW
J Am Heart Assoc; 2018 Dec; 7(24):e009480. PubMed ID: 30561256
[TBL] [Abstract][Full Text] [Related]
7. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
[TBL] [Abstract][Full Text] [Related]
8. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
[TBL] [Abstract][Full Text] [Related]
9. Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial.
Gupta A; Whiteley WN; Godec T; Rostamian S; Ariti C; Mackay J; Whitehouse A; Janani L; Poulter NR; Sever PS;
Eur Heart J; 2024 Apr; 45(13):1159-1169. PubMed ID: 38291599
[TBL] [Abstract][Full Text] [Related]
10. Effects of Amlodipine and Valsartan on Blood Pressure Variability and Pulse Wave Velocity in Hypertensive Patients.
Shi R; Liu K; Shi D; Liu Q; Chen X
Am J Med Sci; 2017 Jan; 353(1):6-11. PubMed ID: 28104105
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Blood Pressure Variability Between Losartan and Amlodipine in Essential Hypertension (COMPAS-BPV).
Lee JW; Choi E; Son JW; Youn YJ; Ahn SG; Ahn MS; Kim JY; Lee SH; Yoon J; Ryu DR; Park SM; Hong KS; Yoo BS
Am J Hypertens; 2020 Aug; 33(8):748-755. PubMed ID: 32267481
[TBL] [Abstract][Full Text] [Related]
12. [Effect of a fixed-dose combination of perindopril arginine/amlodipine on the level and variability of blood pressure according to its office visit-to-visit measurements and self-measurements at home: A subanalysis of the PREVOSHODSTVO (SUPERIORITY) program].
Ostroumova OD
Ter Arkh; 2017; 89(8):29-36. PubMed ID: 28914848
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Fixed-Dose Perindopril/Amlodipine on Clinic, Ambulatory and Self-Monitored Blood Pressure and Blood Pressure Variability: An Open-Label, Non Comparative Study in the General Practice.
Karpov YA; Gorbunov VM; Deev AD
High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):417-25. PubMed ID: 26351011
[TBL] [Abstract][Full Text] [Related]
15. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease.
Mallamaci F; Minutolo R; Leonardis D; D'Arrigo G; Tripepi G; Rapisarda F; Cicchetti T; Maimone I; Enia G; Postorino M; Santoro D; Fuiano G; De Nicola L; Conte G; Zoccali C
Kidney Int; 2013 Aug; 84(2):381-9. PubMed ID: 23615498
[TBL] [Abstract][Full Text] [Related]
16. Associations between visit-to-visit variability in blood pressure measured in the office and antihypertensive drugs: the J-HOME-Morning study.
Obara T; Kikuya M; Kobayashi Y; Ishikura K; Ikeda U; Ishikuro M; Metoki H; Mano N; Kuriyama S; Ohkubo T; Imai Y;
Clin Exp Hypertens; 2013; 35(4):285-90. PubMed ID: 23557293
[TBL] [Abstract][Full Text] [Related]
17. Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy study: 16-year follow-up results of a randomised factorial trial.
Gupta A; Mackay J; Whitehouse A; Godec T; Collier T; Pocock S; Poulter N; Sever P
Lancet; 2018 Sep; 392(10153):1127-1137. PubMed ID: 30158072
[TBL] [Abstract][Full Text] [Related]
18. The Association Between Antihypertensive Medication Nonadherence and Visit-to-Visit Variability of Blood Pressure: Findings From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Kronish IM; Lynch AI; Oparil S; Whittle J; Davis BR; Simpson LM; Krousel-Wood M; Cushman WC; Chang TI; Muntner P
Hypertension; 2016 Jul; 68(1):39-45. PubMed ID: 27217410
[TBL] [Abstract][Full Text] [Related]
19. Within-visit and between-visit intra-individual blood pressure variability in an unselected adult population from rural China.
Fan WG; Wang WY; Meng YX; Sharman JE; Parati G; Campbell NRC; Su H
J Hypertens; 2021 Jul; 39(7):1346-1351. PubMed ID: 33967241
[TBL] [Abstract][Full Text] [Related]
20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
